An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.
![Third shot of COVID-19 vaccine not justified, says research](https://www.advancedsciencenews.com/wp-content/uploads/2021/09/mat-napo-BBdKPGfEGUI-unsplash.jpg)
An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.
Two vaccines in early development are stable under high temperatures and could be game changers in global vaccine equity.
Dendritic cell vaccines offer a unique opportunity in biomedicine, and limitations in efficacy can now potentially be overcome using graphene oxide nanosheets.
COVID-19 is unlikely to be the last coronavirus to spill over to humans. Scientists are working to make a universal vaccine to combat future outbreaks.
Large-scale recoding of virus genomes has the potential for use in vaccine design.
Integrating vaccines with biomaterials could help minimize the need for refrigeration and booster shots.
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.
In a historic and surprise move, this week the US declared its support for a patent waiver on COVID-19 vaccines.